Phospho-Axl (Tyr702) (D12B2) Rabbit mAb 5724S from Cell Signaling Technology

Product Specs
ItemPhospho-Axl (Tyr702) (D12B2) Rabbit mAb
CompanyCell Signaling Technology
Price $401.00 Inquire
Catalog Number5724S
Quantity100 µl
ApplicationsW
ReactivityH
TargetAxl (Tyr702) phosphate
ModificationsAxl (Tyr702/Tyr703) phosphate
HostRabbit
NCBI Gene AliasesARK, JTK11, Tyro7, UFO
ClonalityMonoclonal
NCBI Full Gene NameAXL receptor tyrosine kinase
Research AreaRTK
IsotypeIgG
CloneD12B2
Molecular Weight138

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Ribonuclease 4 Functions in Nociceptor-Mediated Nerve HomeostasisNat CommunMarch 24, 2026Xiaona Feng, Kaiwen Zhang, Prach Techameena, Rolen M. Quadros, Csaba Adori, Aliia Murtazina, Igor Adameyko, Sofia Biagini, Ozun Gokce Bayramlik, Francois Lallemend, et al.°C at a concentration of 1:1000: rabbit anti-Axl (CST, 8661), rabbit anti-phospho-Axl Tyr702 (CST, 5724), rabbit anti-mTOR (CST, 2983), rabbit anti-phospho-mTOR Ser2448 (CST, 5536), rabbit anti-Akt (CST,

(2) Differential AXL expression and Arf1 regulation control stiffness-dependent Golgi organization in breast cancer cellsJournal of Cell ScienceJanuary 15, 2026Arnav Saha, Tushar Sherkhane, Nagaraj Balasubramanian9272S (1:1000); AXL (C89E7), cat. no. 8661S (1:2000) and phospho-Axl (Tyr702) (D12B2) (Y702), cat. no. 5724S (1:1000) [all purchased from Cell Signaling Technology (CST)]; GAPDH, cat. no. #9545 (1:5000) (Sigma);

(3) CD146 + pericyte-like lung cancer brain metastatic stem cells promote tumor angiogenesis through dual regulatory effects on the VEGF/VEGFR axisTheranosticsJanuary 1, 2026Wenwen Liu, Wenzhe Duan, Shengkai Xia, Ye Liu, Huiying Chu, Kun Liang, Shaobo Fang, Manqing Lin, Song Wei, Xin You, et al.(18704-1-AP, Proteintech, RRID:AB_10597232), AXL (13196-1-AP, Proteintech, RRID:AB_10642006), phospho-AXL (5724, Cell Signaling Technology, RRID:AB_10544794), GAS6 (13795-1-AP, Proteintech, RRID:AB_2756522), GFAP

(4) A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung CancerBiomedicinesDecember 28, 2025Byung-Ho Rhie, Janardhan Keshav Karapurkar, Hyun-Yi Kim, Sang Hyeon Woo, D. A. Ayush Gowda, Dong Ha Kim, Myeong Jun Choi, Young Jun Park, Viswanathaiah Matam, Yoonki Hong, et al.hFRS2α (Cell Signaling, #3861), anti-hAxl (Cell Signaling, #8661), anti-phospho-hAxl (Cell Signaling, #5724), anti-Akt (Cell Signaling, #9272), anti-phospho-Akt (Cell Signaling, #9271), anti-ERK (Cell Signaling,

(5) Redundancy of the OST catalytic subunit facilitates therapeutic targeting of N-glycosylationCell Chemical BiologyJune 19, 2025Marta Baro, Hojin Lee, Vanessa Kelley, Rongliang Lou, Chatchai Phoomak, Katerina Politi, Caroline J. Zeiss, Michael Van Zandt, Joseph N. ContessaReceptor β (D23H3),Cell Signaling,Cat#9750S; RRID: AB_10950969 rabbit anti-pAxl Y702,Cell Signaling,Cat#5724S; RRID: AB_10544794 rabbit anti-Axl,Cell Signaling,Cat#8661S; RRID: AB_11217435 rabbit anti-pErbB3

(6) Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithmExp Ther MedApril 4, 2025Yoonjung Choi, Heejin Lee, Bo Ram Beck, Bora Lee, Ji Hyun Lee, Seoree Kim, Sang Hoon Chun, Hye Sung Won, Yoon Ho Kousing the NEW Clarity ECL substrate (GE Healthcare, Chicago, IL, USA). Antibodies for phospho-AXL (#5724), AXL (#8661), and TYRO3 (#5585) were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies

(7) AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated AKT pathwayCell Mol Life SciFebruary 27, 2025Sébastien Pirson, Marine Gautier-Isola, Louis Baudin, Loïc Rouaud, Aline Vanwynsberghe, Jonathan Deroye, Sophie Bekisz, Fabrice Gucciardo, Alizée Lebeau, Florence Buntinx, et al.(Cell Signaling Technology Cat# 8661, RRID: AB_11217435), anti-pAXL (Tyr702, Cell Signaling Technology Cat# 5724, RRID: AB_10544794), anti-pAKT (Ser473, Cell Signaling Technology Cat# 9271 (also 9271 S, 9271 L, NYUIHC-310),

(8) Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)Cell death & diseaseJanuary 9, 2025Chen X, Zeng Q, Yin L, Yan B, Wu C, Feng J, Wu Y, He J, Ding W, Zhong J, et al.vivo trials. The following antibodies were employed: phospho-FGR (Y412) (Cell Signaling Technology #5724), FGR (Cell Signaling Technology, #8198), β-actin (Cell Signaling Technology, #4970), DKK1 (Proteintech,

(9) Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT PathwayTransplantationNovember 1, 2024Mengting Zhan, Deng Liu, Lei Yao, Weizhi Wang, Ruixin Zhang, Yaru Xu, Zhen Wang, Qi Yan, Qi Fang, Jian Du, et al.number,Dilution AXL,Proteintech,China,13196-1-AP,1:1000 AXL,CST,United States,No. 8661,1:1000 p-AXL,CST,United States,No. 5724,1:500 TFR1,Affinity,China,AF5343,1:1000 FTH1,Affinity,China,DF6278,1:1000 ACSL4,Affinity,China,DF12141,1:1000 GPX4,Affinity,China,DF6701,1:1000 SLC7A11,Duoning-BIO,China,AB0138101,1:500 p-PI3K,Proteintech,China,AF3242,1:1000 PI3K,Wanleibio,China,WL03380,1:1000 p-AKT,Zenbio,China,381555,1:1000 AKT,Wanleibio,China,WL0003b,1:1000 4-HNE,R&D systems

(10) Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activityHeliyonOctober 15, 2024Matsuda T, Kaji K, Nishimura N, Asada S, Koizumi A, Tanaka M, Yorioka N, Tsuji Y, Kitagawa K, Sato S, et al.added and incubated overnight at 4 °C. The primary antibodies include rabbit Phospho-AXL (Tyr702; #5724; 1:1000), rabbit AXL (#8661; 1:1000), rabbit Phospho-Akt (Ser473; #9271; 1:1000), and rabbit Akt (#9272;

(11) Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathwayRespiratory ResearchMay 20, 2024Han Wang, Xiaohui Du, Wenwen Liu, Congcong Zhang, Ying Li, Jingwen Hou, Yi Yu, Guiru Li, Qi Wang(1:1000, CST, USA, 3777), p-MET (Tyr1234/1235) (1:1000, CST, USA, 3077), p-AXL (Tyr702) (1:1000, CST, USA, 5724), p-Her2 (Tyr1221/1222) (1:1000, CST, USA, 2243), C-PARP (1:1000, CST, USA, 5625), p-AKT (Ser473) (1:1000,

(12) Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAsAging (Albany NY)January 8, 2024Zhen Wang, Anfang He, Zhengyu Lu, Wenli Xu, Gang Wu, Tingsheng Pengtemperature for 1 hour. The antibodies were used: AXL (1:1,000; 8661S; CST), phospho-AXL (1:1,000; 5724S; CST), AKT (1:1,000; 4691S; CST), phospho-AKT (1:2,000; 4060S; CST), and GAPDH (1:1,000; 2118S; CST). CCK-8,

(13) PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular CarcinomaCancersApril 22, 2023Hedrich V, Breitenecker K, Ortmayr G, Pupp F, Huber H, Chen D, Sahoo S, Jolly MK, Mikulits W.primary antibodies were used at a dilution of 1:1000 if not indicated otherwise: anti-phospho-Axl (#5724), anti-phospho-Erk1/2 (#9101), anti-Erk1/2 (#4695), anti-phospho-Src (#6943) and anti-Src (#2109) were

(14) Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and MetastasisCancersMarch 21, 2023Kim J, Nam G, Shin YK, Vilaplana-Lopera N, Jeung HC, Moon EJ, Lee IJ.and subsequently probed with primary antibodies against phospho-AXL (Tyr702) (1:1000, Cell signaling #5724S), AXL (1:2000, Santa Cruz #sc-1096), phospho-AKT (1:1000, Cell signaling #4060), AKT (1:1000, Cell signaling

(15) Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MERMolecular cancer therapeuticsFebruary 1, 2023Hsu J, Chong C, Serrill J, Goon L, Balayan J, Johnson EN, Lorenzana G, Wu S, Leong KG, Yun TJ, et al.For Western blot analysis, antibodies used were from Cell Signaling Technology [VEGFR2 (#9698), pAXL (#5724), and cMET (#4560S)], Thermo Fisher Scientific [pVEGFR2 (#44-1047G) and pMET (#44-88G)] and Abcam [AXL

(16) Axl contributes to efficient migration and invasion of melanoma cellsPloS oneJanuary 1, 2023Shao H, Teramae D, Wells A.(Cat #: 3787S), pERK (Cat #: 4370S), pP38 (Cat #:4511S), GAPDH (Cat #: 5174S), pAxl (Y702) (Cat #: 5724S) were purchased from Cell Signaling Technology. Monoclonal antibodies against Axl (Cat #:sc-166269),

(17) Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signalingThe ProstateNovember 1, 2022Brown NE, Jones A, Hunt BG, Waltz SE.Src (2110 S), phosphor‐Src y416 (2101 S), Akt (4691 S), phosphor‐Akt s473 (4060S), phospho‐Axl y702 (5724S), and LAMIN A/C (4777S) from Cell Signaling Technologies; phospho‐RON y1238/y1239 (AF1947, R&D); ACTIN

(18) Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumorsFrontiers in ImmunologyOctober 20, 2022Yu-Xiang Ma, Fu-Rong Liu, Yang Zhang, Qun Chen, Zhi-Qiang Chen, Qian-Wen Liu, Yan Huang, Yun-Peng Yang, Wen-Feng Fang, Ning Xi, et al.: AB_10786128), anti-AXL (Cell Signaling Technology Cat# 4566, RRID : AB_2062563), anti-p-AXL Y702 (5724S), anti-ERK (9107S), anti-p-ERK Thr202/Tyr204 (4370S), anti-p-AKT Ser473 (4060S), and anti-AKT (Cell Signaling Technology

(19) A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor MicroenvironmentCancersOctober 2, 2022Jeon Y, Kang H, Yang Y, Park D, Choi B, Kim J, Kim J, Nam K.were used in western blotting: phospho-Axl-(Tyr702) (Cell Signaling Technology, Danvers, MA, USA; #5724, clone D12B2), Axl (Cell Signaling Technology; #8661, clone C89E7), phospho-AKT(Ser473) (Cell Signaling Technology

(20) Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinomaCell reports. MedicineSeptember 20, 2022Hagege A, Saada-Bouzid E, Ambrosetti D, Rastoin O, Boyer J, He X, Rousset J, Montemagno C, Doyen J, Pedeutour F, et al.following primary antibodies were used: Plk1 (Abcam, ab17056, mouse), phospho-AXL (Cell signaling, #5724S), phospho-MET (Cell signaling, #3077S), phospho-AKT (Cell signaling, #9271S), phospho-SRC (Cell signaling,

Be the First to Write a Review!

Phospho-Axl (Tyr702) (D12B2) Rabbit mAb

Phospho-Axl (Tyr702) (D12B2) Rabbit mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (55)

Reviews

Phospho-Axl (Tyr702) (D12B2) Rabbit mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map